Publications by authors named "P-M Diagne"
Article Synopsis
- A lot of money has been spent on studying the COVID-19 virus in Africa, leading to over 100,000 virus samples being analyzed to understand the spread of the disease.
- *More countries in Africa are now able to do these studies themselves, which helps them get results faster and keep a close watch on the virus.
- *To keep fighting COVID and other diseases, more funding and support for testing and research in Africa is really important for the future.
Article Synopsis
- The SARS-CoV-2 pandemic in Africa has varied significantly across countries, and its overall impact remains unclear.
- An analysis of 8,746 genomes from 33 African countries indicated that most outbreaks originated from Europe before international travel restrictions took effect.
- As the pandemic continued, increased movement and local transmission led to the emergence of several variants within Africa, emphasizing the need for a strong pandemic response on the continent to prevent becoming a source of new variants.
During the 2018-2020 Ebola virus disease (EVD) outbreak in North Kivu province in the Democratic Republic of Congo, EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus-based vaccine expressing a ZEBOV glycoprotein (rVSV-ZEBOV) (Merck). His treatment included an Ebola virus (EBOV)-specific monoclonal antibody (mAb114), and he recovered within 14 days. However, 6 months later, he presented again with severe EVD-like illness and EBOV viremia, and he died.
View Article and Find Full Text PDF